Liquidia (LQDA) Names Dana Boyle Chief Accounting Officer, Grants $300k RSUs

AG真人官方

AG真人官方

[S-8 POS] Everi Holdings Inc SEC Filing

Insights

FAQ

[S-8 POS] Everi Holdings Inc SEC Filing

Insights

FAQ

[S-8 POS] Everi Holdings Inc SEC Filing

Insights

Financial Governance Analyst positive

Portfolio Manager 鈥� Small-Cap Biopharma neutral

FAQ

Q: Who is Liquidia's new Chief Accounting Officer and when was she appointed?

Q: What is the base salary and bonus opportunity for LQDA's new CAO?

Q: How many restricted stock units did Dana Boyle receive from Liquidia?

Q: What severance benefits could the CAO receive upon termination?

Q: Does the 8-K disclose any related-party transactions involving Ms. Boyle?

Who is Liquidia's new Chief Accounting Officer and when was she appointed?

What is the base salary and bonus opportunity for LQDA's new CAO?

How many restricted stock units did Dana Boyle receive from Liquidia?

What severance benefits could the CAO receive upon termination?

Does the 8-K disclose any related-party transactions involving Ms. Boyle?

Who is Liquidia's new Chief Accounting Officer and when was she appointed?

What is the base salary and bonus opportunity for LQDA's new CAO?

How many restricted stock units did Dana Boyle receive from Liquidia?

What severance benefits could the CAO receive upon termination?

Does the 8-K disclose any related-party transactions involving Ms. Boyle?

NYSE:EVRI

EVRI Rankings

EVRI Latest News

EVRI Latest SEC Filings

EVRI Stock Data

Who is Liquidia's new Chief Accounting Officer and when was she appointed?

What is the base salary and bonus opportunity for LQDA's new CAO?

How many restricted stock units did Dana Boyle receive from Liquidia?

What severance benefits could the CAO receive upon termination?

Does the 8-K disclose any related-party transactions involving Ms. Boyle?

NYSE:EVRI

EVRI Rankings

EVRI Latest News

EVRI Latest SEC Filings

EVRI Stock Data

Trending News

Dana Boyle was appointed CAO effective July 1, 2025.

Boyle will earn a $425,000 base salary and is eligible for a 50 % annual cash bonus.

She received RSUs valued at $300,000 on the grant date, vesting over four years.

She may receive 12 months of salary, COBRA premiums, and accelerated equity vesting if terminated during a change-in-control period.

No. The filing states no direct or indirect material interests under Item 404(a).

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

S-8 POS

Rhea-AI Filing Summary

Liquidia Corporation (Nasdaq: LQDA) filed a Form 8-K announcing the appointment of Dana Boyle as Chief Accounting Officer effective July 1, 2025. Boyle, 41, has led the company鈥檚 accounting function since January 2021 as SVP-Finance and Controller. Her background includes senior finance roles at Aerami Therapeutics and Aralez Pharmaceuticals, plus public-accounting experience at Deloitte & Touche. She is a licensed CPA (NY) and holds a B.S. in Accounting from Rutgers University.

Compensation package:

Annual base salary: $425,000
Target cash bonus: 50 % of base salary
Equity award: Restricted Stock Units valued at $300,000 on the effective date. Vesting schedule: 25 % on July 11, 2026; remaining 75 % in equal quarterly installments over the following three years, subject to continued employment.

Severance terms: Under the Amended & Restated Executive Severance and Change in Control Plan, Boyle is entitled to up to 12 months of salary continuation, COBRA premium payments, and鈥攊f terminated within a change-in-control period鈥攁ccelerated vesting of 100 % of unvested equity plus target bonus payout.

The filing states that no family relationships or related-party transactions exist. The appointment was not made pursuant to any arrangement with other parties.

Investor take-away: While the event does not directly influence revenue or near-term financials, installing a seasoned CAO may enhance financial reporting quality and internal controls鈥攁n incremental positive for governance鈥恌ocused investors.

Liquidia Corporation (雮橃姢雼�: LQDA)電� 2025雲� 7鞗� 1鞚茧秬搿� Dana Boyle鞚� 斓滉碃須岅硠毂呾瀯鞛�(Chief Accounting Officer)搿� 鞛勲獏頄堧嫟瓿� Form 8-K毳� 韱淀暣氚滍憸頄堨姷雼堧嫟. 41靹胳澑 Boyle鞚€ 2021雲� 1鞗旊秬韯� SVP-鞛 氚� 旎姼搿る煬搿滌劀須岇偓鞚� 須岅硠攵€靹滊ゼ鞚措亴鞏� 鞕旍姷雼堧嫟. 攴鸽厐電� Aerami Therapeutics鞕€ Aralez Pharmaceuticals鞐愳劀瓿犾渼鞛歆侅潉鞐瀯頄堨溂氅� Deloitte & Touche鞐愳劀瓿店车須岅硠瓴巾棙霃� 氤挫湢頃橁碃鞛堨姷雼堧嫟. 雺挫殨欤� 瓿奠澑須岅硠靷�(CPA) 鞛愱博歃濎潉靻岇頃橁碃鞛堨溂氅� Rutgers 雽€頃欔祼鞐愳劀須岅硠頃� 頃欖偓頃欖渼毳� 旆摑頄堨姷雼堧嫟.

氤挫儊韺偆歆€:

鞐半磯旮半掣旮�: 425,000雼煬
氇╉憸順勱笀氤措剤鞀�: 旮半掣旮夓潣 50%
欤检嫕氤挫儊: 氚滍毃鞚� 旮办 臧€旃� 30毵� 雼煬靸侂嫻鞚� 鞝滍暅欤检嫕雼渼(RSU). 氩犾姢韺� 鞚检爼: 2026雲� 7鞗� 11鞚检棎 25% 氩犾姢韺�; 鞚错泟 3雲勱皠攵勱赴氤� 攴犽摫攵勴暊搿� 雮橂ǜ歆€ 75% 氩犾姢韺�, 瓿勳啀攴茧 臁瓣贝.

韲挫旮� 臁瓣贝: 臧滌爼氚� 鞛瀾靹彪悳鞛勳洂韲挫 氚� 瓴届榿甓� 氤€瓴� 瓿勴殟鞐� 霐半澕 Boyle鞚€ 斓滊寑 12臧滌洈旮夓棳歆€靻�, COBRA 氤错棙耄� 歆€旮�, 攴鸽Μ瓿� 瓴届榿甓� 氤€瓴� 旮瓣皠雮� 頃搓碃鞁� 氙鸽矤鞀ろ寘欤检嫕 100% 臧€靻� 氩犾姢韺呹臣氇╉憸氤措剤鞀� 歆€旮夓潉氚涭潉甓岆Μ臧€ 鞛堨姷雼堧嫟.

靹滊鞐愲姅臧€臁� 甏€瓿勲倶甏€霠� 雼轨偓鞛� 瓯半灅臧€ 鞐嗢溂氅�, 鞛勲獏鞚€ 韮€鞚戈臣鞚� 鞏措枲頃� 頃╈潣鞐� 霐半ジ瓴冹澊鞎勲嫎鞚� 氇呾嫓頃橁碃鞛堨姷雼堧嫟.

韴瀽鞛� 鞁滌偓鞝�: 鞚措矆鞛勲獏鞚� 歆侅爲鞝侅澑靾橃澋鞚措倶雼赴鞛鞐� 鞓來枼鞚� 氙胳箻歆€ 鞎婌毵�, 瓴巾棙毵庫潃 CAO 鞛勲獏鞚€ 鞛 氤搓碃頀堨 氚� 雮措秬韱奠牅臧滌劆鞐� 旮办棳頃� 靾� 鞛堨柎瓯半矂雱岇姢鞐� 欷戩爯鞚� 霊� 韴瀽鞛愳棎瓴� 旮嶌爼鞝侅澑鞖旍唽鞛呺媹雼�.

Liquidia Corporation (Nasdaq : LQDA) a d茅pos茅 un formulaire 8-K annon莽ant la nomination de Dana Boyle au poste de Chief Accounting Officer 脿 compter du 1er juillet 2025. Boyle, 41 ans, dirige la fonction comptable de l鈥檈ntreprise depuis janvier 2021 en tant que SVP-Finance et Contr么leur. Elle poss猫de une exp茅rience dans des postes financiers seniors chez Aerami Therapeutics et Aralez Pharmaceuticals, ainsi qu鈥檜ne exp茅rience en comptabilit茅 publique chez Deloitte & Touche. Elle est CPA agr茅茅e (NY) et d茅tient un B.S. en comptabilit茅 de l鈥橴niversit茅 Rutgers.

Package de r茅mun茅ration :

Salaire de base annuel : 425 000 $
Bonus en esp猫ces cible : 50 % du salaire de base
Attribution d鈥檃ctions : unit茅s d鈥檃ctions restreintes (RSU) d鈥檜ne valeur de 300 000 $ 脿 la date d鈥檈ntr茅e en vigueur. Calendrier d鈥檃cquisition : 25 % le 11 juillet 2026 ; les 75 % restants en versements trimestriels 茅gaux sur les trois ann茅es suivantes, sous r茅serve de la poursuite de l鈥檈mploi.

Conditions d鈥檌ndemnit茅 : En vertu du plan modifi茅 et r茅vis茅 d鈥檌ndemnit茅 pour cadres et de changement de contr么le, Boyle a droit 脿 une continuation de salaire jusqu鈥櫭� 12 mois, au paiement des primes COBRA et鈥攅n cas de licenciement pendant une p茅riode de changement de contr么le鈥斆� un acquittement acc茅l茅r茅 de 100 % des actions non acquises ainsi qu鈥檃u paiement du bonus cible.

Le d茅p么t pr茅cise qu鈥檃ucune relation familiale ni transaction avec des parties li茅es n鈥檈xiste. La nomination n鈥檃 pas 茅t茅 faite en vertu d鈥檜n accord avec d鈥檃utres parties.

脌 retenir pour les investisseurs : Bien que cet 茅v茅nement n鈥檃it pas d鈥檌mpact direct sur les revenus ou les r茅sultats financiers 脿 court terme, la nomination d鈥檜n CAO exp茅riment茅 pourrait am茅liorer la qualit茅 des rapports financiers et les contr么les internes鈥攗n point positif suppl茅mentaire pour les investisseurs ax茅s sur la gouvernance.

Positive

Appointment of a licensed CPA with biotech experience strengthens financial reporting and internal controls.
Equity-based compensation aligns the new CAO鈥檚 incentives with long-term shareholder value.

Negative

None.

TL;DR 鈥� Experienced CAO hired; improves accounting oversight, modestly positive governance signal.

The appointment of Dana Boyle consolidates Liquidia鈥檚 finance leadership under a credentialed CPA with both biotech and public-company expertise. Stable, competent accounting leadership is particularly important as Liquidia advances late-stage pulmonary hypertension programs that will add complexity to revenue recognition and R&D capitalization once commercialized. The equity-heavy compensation aligns Boyle鈥檚 incentives with shareholders over a multi-year horizon, and the severance framework is market-standard, containing double-trigger acceleration only in a change-in-control scenario. No red flags on related-party dealings or excessive payouts are evident. Overall impact is mildly positive for governance and internal-control risk profile, but not a catalyst for valuation in the near term.

TL;DR 鈥� Neutral to portfolio returns; strengthens back-office, not thesis-shifting.

From an investment perspective, this 8-K is routine. A CAO transition rarely affects modelled cash flows or probability-of-success on drug candidates. The compensation levels are consistent with peers at similar market caps (<$1 bn), and the RSU vesting promotes retention through key regulatory milestones expected in the next three years. I see no change to risk-adjusted valuation or target price, but governance score ticks up slightly, which could marginally broaden the institutional investor base.

氤挫儊韺偆歆€:

鞐半磯旮半掣旮�: 425,000雼煬
氇╉憸順勱笀氤措剤鞀�: 旮半掣旮夓潣 50%
欤检嫕氤挫儊: 氚滍毃鞚� 旮办 臧€旃� 30毵� 雼煬靸侂嫻鞚� 鞝滍暅欤检嫕雼渼(RSU). 氩犾姢韺� 鞚检爼: 2026雲� 7鞗� 11鞚检棎 25% 氩犾姢韺�; 鞚错泟 3雲勱皠攵勱赴氤� 攴犽摫攵勴暊搿� 雮橂ǜ歆€ 75% 氩犾姢韺�, 瓿勳啀攴茧 臁瓣贝.

Package de r茅mun茅ration :

Salaire de base annuel : 425 000 $
Bonus en esp猫ces cible : 50 % du salaire de base
Attribution d鈥檃ctions : unit茅s d鈥檃ctions restreintes (RSU) d鈥檜ne valeur de 300 000 $ 脿 la date d鈥檈ntr茅e en vigueur. Calendrier d鈥檃cquisition : 25 % le 11 juillet 2026 ; les 75 % restants en versements trimestriels 茅gaux sur les trois ann茅es suivantes, sous r茅serve de la poursuite de l鈥檈mploi.

07/01/2025 - 04:16 PM

As filed with the Securities and Exchange Commission on July 1, 2025

Registration No. 333-280586

Registration No. 333-256298

Registration No. 333-218302

Registration No. 333-202798

Registration No. 333-197860

Registration No. 333-187199

Registration No. 333-172358

Registration No. 333-165264

Registration No. 333-157512

Registration No. 333-149496

Registration No. 333-140878

Registration No. 333-131904

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-280586

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-256298

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-218302

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-202798

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-197860

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-187199

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-172358

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-165264

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-157512

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-149496

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-140878

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-131904

UNDER

THE SECURITIES ACT OF 1933

Everi Holdings Inc.

(Exact name of the registrant as specified in its charter)


Delaware	Everi Holdings Inc. Amended & Restated 2014 Equity Incentive Plan Global Cash Access Holdings, Inc. 2014 Equity Incentive Plan Multimedia Games Holding Company, Inc. 2012 Equity Incentive Plan Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan Notice of Stock Option Award and Stock Option Award Agreement with Harry C. Hagerty	20-0723270
(State or other jurisdiction of incorporation or organization)	(Full titles of plans)	(I.R.S. Employer Identification No.)
7250 S. Tenaya Way, Suite 100 Las Vegas, Nevada	Mark F. Labay Executive Vice President, Chief Financial Officer and Treasurer Everi Holdings Inc. 7250 S. Tenaya Way, Suite 100 Las Vegas, Nevada 89113 (Name and address of agent for service) (800) 833-7110 (Telephone number, including area code, of agent for service) Copies to: Davina K. Kaile Pillsbury Winthrop Shaw Pittman LLP 2550 Hanover Street Palo Alto, CA 94304 (650) 233-4500	89113
(Address of principal executive offices)		(Zip Code)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

DEREGISTRATION OF SECURITIES

This Post-Effective Amendment No. 1 (the “Post-Effective Amendment”) is being filed by Everi Holdings Inc., a Delaware corporation (the “Registrant”) to deregister all shares of the Registrant’s common stock, par value $0.001 per share (“Common Stock”), which are unsold under the following Registration Statements on Form S-8 (each, a “Registration Statement,” and collectively, the “Registration Statements”), filed by the Registrant with the Securities and Exchange Commission:

•

Registration Statement No. 333-280586, filed on June 28, 2024, registering 3,590,000 shares of Common Stock under the Everi Holdings Inc. Amended & Restated 2014 Equity Incentive Plan;

•

Registration Statement No. 333-256298, filed on May 19, 2021, registering 5,000,000 shares of Common Stock under the Everi Holdings Inc. Amended & Restated 2014 Equity Incentive Plan;

•

Registration Statement No. 333-218302, filed on May 26, 2017, registering 3,500,000 shares of Common Stock under the Everi Holdings Inc. Amended & Restated 2014 Equity Incentive Plan;

•

Registration Statement No. 333-202798, filed on March 16, 2015, registering 4,117,917 shares of Common Stock under the Multimedia Games Holding Company, Inc. 2012 Equity Incentive Plan;

•

Registration Statement No. 333-197860, filed on August 5, 2014, registering 10,275,000 shares of Common Stock under the Global Cash Access Holdings, Inc. 2014 Equity Incentive Plan;

•

Registration Statement No. 333-187199, filed on March 12, 2013, registering 3,174,064 shares of Common Stock under the Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan;

•

Registration Statement No. 333-172358, filed on February 18, 2011, registering 1,931,400 shares of Common Stock under the Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan;

•

Registration Statement No. 333-165264, filed on March 5, 2010, registering 2,500,334 shares of Common Stock under the Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan;

•

Registration Statement No. 333-157512, filed on February 25, 2009, registering 2,488,819 shares of Common Stock under the Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan;

•

Registration Statement No. 333-149496, filed on March 3, 2008, registering 2,501,369 shares of Common Stock under the Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan;

•

Registration Statement No. 333-140878, filed on February 26, 2007, registering 2,469,376 shares of Common Stock under the Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan; and

•

Registration Statement No. 333-131904, filed on February 16, 2006, registering 722,215 shares of Common Stock under the Notice of Stock Option Award and Stock Option Award Agreement with Harry C. Hagerty and 6,288,222 shares of Common Stock under the Global Cash Access Holdings, Inc. 2005 Stock Incentive Plan.

On July 1, 2025, pursuant to the terms and conditions of the previously disclosed definitive agreements executed on July 26, 2024 by and among the Registrant, International Game Technology PLC, a public limited company incorporated under the laws of England and Wales (“IGT”), Ignite Rotate LLC, a Delaware limited liability company and a direct wholly owned subsidiary of IGT (“Spinco”), Voyager Parent, LLC, a Delaware limited liability company owned by funds managed by affiliates of Apollo Global Management, Inc. (“Buyer”), and Voyager Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Buyer (“Buyer Sub,” and together with the Registrant, IGT, Spinco, and Buyer, the “Parties”), the Parties completed certain transactions, as a result of which, among other matters, Everi and IGT’s Gaming & Digital business were simultaneously acquired by Buyer.

Pursuant to the terms and subject to the conditions of the definitive agreements:

•

IGT transferred, or caused to be transferred, to Spinco substantially all of the assets, and Spinco assumed substantially all of the liabilities of IGT’s Gaming and Digital business (the “Separation”);

•

Immediately following the Separation and immediately prior to the consummation of the Merger (as defined below), (i) Buyer purchased from IGT, and IGT sold to Buyer, all of the outstanding units of Spinco (the “Equity Sale”); and (ii) Voyager Canada BidCo Limited, an affiliate of Buyer, purchased from IGT, and IGT sold to Voyager Canada BidCo Limited, all of the outstanding shares in the capital stock of IGT Canada Solutions ULC (the “Canada Sub Equity Interests Sale”); and

•

Immediately following the consummation of the Equity Sale and the Canada Sub Equity Interests Sale and at the effective time of the Merger (the “Merger Effective Time”):

•

Buyer Sub was merged with and into the Registrant, with the Registrant surviving the Merger as a direct wholly owned subsidiary of Buyer (the “Merger”).

As a result of the Merger and in connection with the delisting and the deregistration of the Registrant’s securities under Section 12(b) of the Securities Exchange Act of 1934, as amended, the Registrant is terminating all offerings of its securities pursuant to its existing registration statements under the Securities Act of 1933, as amended, including the Registration Statements. Pursuant to the undertaking made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities that had been registered that remain unsold at the termination of the offering, the Registrant is filing this Post-Effective Amendment to terminate the effectiveness of such Registration Statements and to deregister, as of the effectiveness of this Post-Effective Amendment, any and all shares of Common Stock registered thereunder that remain unsold as of the effectiveness date. Upon the effectiveness of this Post-Effective Amendment, no shares of Common Stock will remain registered for sale pursuant to the Registration Statements.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Las Vegas, State of Nevada, on July 1, 2025.


EVERI HOLDINGS INC.

By:		/s/ Mark F. Labay
		Mark F. Labay Executive Vice President, Chief Financial Officer and Treasurer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Randy L. Taylor, Mark F. Labay, and Todd A. Valli and each of them, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Post-Effective Amendment to the Registration Statements and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Post-Effective Amendment to the Registration Statements has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.


Signature	Title	Date

/s/ RANDY L. TAYLOR	President and Chief Executive Officer and Director	July 1, 2025
Randy L. Taylor	(Principal Executive Officer)

/s/ MARK F. LABAY	Executive Vice President, Chief Financial Officer	July 1, 2025
Mark F. Labay	(Principal Financial Officer) and Treasurer

/s/ TODD A. VALLI	Senior Vice President, Chief Accounting Officer	July 1, 2025
Todd A. Valli	(Principal Accounting Officer)

/s/ MICHAEL D. RUMBOLZ	Executive Chair of the Board	July 1, 2025
Michael D. Rumbolz	Director

/s/ ATUL BALI	Lead Independent Director	July 1, 2025
Atul Bali

/s/ GEOFFREY P. JUDGE	Director	July 1, 2025
Geoffrey P. Judge

/s/ LINSTER W. FOX	Director	July 1, 2025
Linster W. Fox

/s/ MAUREEN T. MULLARKEY	Director	July 1, 2025
Maureen T. Mullarkey

/s/ SECIL TABLI WATSON	Director	July 1, 2025
Secil Tabli Watson

/s/ PAUL FINCH	Director	July 1, 2025
Paul Finch

/s/ DEBRA L. NUTTON	Director	July 1, 2025
Debra L. Nutton

Source:

Dana Boyle was appointed CAO effective July 1, 2025.

Boyle will earn a $425,000 base salary and is eligible for a 50 % annual cash bonus.

She received RSUs valued at $300,000 on the grant date, vesting over four years.

She may receive 12 months of salary, COBRA premiums, and accelerated equity vesting if terminated during a change-in-control period.

No. The filing states no direct or indirect material interests under Item 404(a).

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company